Fundraising Fox

Orasis Pharmaceuticals

8 known investors

orasis-pharma.com β†—

Orasis is a pharmaceutical company developing drugs for the eye, operating in the ophthalmology and eyecare space. It is backed by healthcare-focused investors and announced a Series D financing in October 2024.

BiotechHealthtechMedical Devices

Investors Β· 8

Arboretum Venturesβœ“ verifiedAnn Arbor Β· $5M – $15M
Maverick Ventures Israelβœ“ verifiedTel Aviv Β· $2M – $5M
Visionary Venturesβœ“ verifiedNewport Beach Β· $5M – $15M
Catalio Capital Managementβœ“ verifiedNew York
Johnson & Johnson Innovation – JJDCβœ“ verifiedNew Brunswick
LifeSci Venture Partnersβœ“ verifiedNew York
Sequoia Capitalβœ“ verifiedMenlo Park Β· $4.4M – $214M
Catalio Capital Management, LPNew York

In the news

Orasis Pharmaceuticals Completes $78 Million Financing to Support Commercial Launch of Qlosiβ„’ (pilocarpine hydrochloride ophthalmic solution) 0.4% - Orasisorasis-pharma.com Β· Oct 2024Orasis Pharmaceuticals raises $30 million in financinghealio.com Β· Sep 2020Orasis Raises $30 Million to Advance the Clinical Development of Novel Treatment for Presbyopia - Orasisorasis-pharma.com Β· Sep 2020Orasis Pharmaceuticals Closes $13 Million Series B Financingorasis-pharma.com Β· Jun 2018

Frequently asked questions

What does Orasis Pharmaceuticals do?
Orasis is a pharmaceutical company developing drugs for the eye, operating in the ophthalmology and eyecare space. It is backed by healthcare-focused investors and announced a Series D financing in October 2024.
Who are Orasis Pharmaceuticals's investors?
Orasis Pharmaceuticals's investors include Arboretum Ventures, Maverick Ventures Israel, Visionary Ventures, Catalio Capital Management, Johnson & Johnson Innovation – JJDC, LifeSci Venture Partners, Sequoia Capital, Catalio Capital Management, LP.